| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5858383 | SHIONOGI INC | Methods and compositions for topical treatment of ectoparasites |
Aug, 2017
(6 years ago) | |
| US6139859 | SHIONOGI INC | Methods and compositions for topical treatment of ectoparasites |
Aug, 2017
(6 years ago) | |
| US6793931 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their applications |
Jul, 2022
(1 year, 9 months ago) | |
| US7294342 | SHIONOGI INC | Ectoparasite asphyxiator compositions and methods for their application |
May, 2024
(21 days from now) | |
Ulesfia is owned by Shionogi Inc.
Ulesfia contains Benzyl Alcohol.
Ulesfia has a total of 4 drug patents out of which 3 drug patents have expired.
Expired drug patents of Ulesfia are:
- US5858383
- US6139859
- US6793931
Ulesfia was authorised for market use on 09 April, 2009.
Ulesfia is available in lotion;topical dosage forms.
Ulesfia can be used as topical treatment of lice infestations.
Drug patent challenges can be filed against Ulesfia from 09 April, 2013.
The generics of Ulesfia are possible to be released after 19 May, 2024.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Apr 09, 2014 |
Drugs and Companies using BENZYL ALCOHOL ingredient
NCE-1 date: 09 April, 2013
Market Authorisation Date: 09 April, 2009
Treatment: Topical treatment of lice infestations
Dosage: LOTION;TOPICAL
ULESFIA family patents
